Cadonilimab (Anti-PD-1 & CTLA-4)
£227.25
Cadonilimab (Anti-PD-1 & CTLA-4) (A4002-1mg)
Product
| Cat # A4002-1mg | Size 1mg |
Price
£227.25
|
Qty
|
Description
Cadonilimab is a humanized tetravalent bispecific IgG1 antibody targeting human PD-1 and CTLA-4 with potential immune checkpoint inhibitory and antineoplastic activities. It has the potential to treat recurrent or metastatic cervical cancer. MW : 198.64 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Product Size | 1mg |
| Manufacturer Cat# | A4002 |
| Target | PD-1/PD-L1 |